Bardet-Biedl syndrome (BBS) is a genetically heterogeneous autosomal recessive disorder characterized by variable obesity, pigmentary retinopathy, polydactyly, mental retardation, hypogonadism and renal failure. In order to identify novel BBS loci we undertook autozygosity mapping studies using high-density SNP microarrays in consanguineous kindreds. We mapped a BBS locus to a 10.1 Mb region at 12q15-q21.2 in a large Omani BBS family (peak lod score 8.3 at h ¼ 0.0 for marker D12S1722) that contained the recently described BBS10 locus. Mutation analysis of candidate genes within the target interval, including the BBS10 gene, revealed a homozygous frameshift mutation in FLJ23560 and mutations were also detected in four smaller consanguineous families with regions of autozygosity at 12q21.2. These findings (a) confirm a previous report that FLJ23560 (BBS10) mutations are a significant cause of BBS, and (b) further demonstrate the utility of high-density SNP array mapping in consanguineous families for the mapping and identification of recessive disease genes.
Introduction
Bardet -Biedl Syndrome (BBS: OMIM 209900) is an autosomal recessively inherited disorder with variable expression. Frequent manifestations include obesity, renal dysplasia, obesity, cognitive impairment, postaxial polydactyly, pigmentary retinal degeneration and hypogonadism. 1 The prevalence of BBS in North America and Europe has been estimated to range from 1:140 000 to 1:160 000 live births, 2 -4 but in Kuwait, Newfoundland and Oman, BBS is more frequent (eg estimated incidences of 1:13 500, 1:17 500 and 1:30 000, respectively). 1, 5, 6 The genetics of BBS are complex and at the start of 2006 nine susceptibility genes had been mapped previously: BBS1 at 11q13 (MIM209901); BBS2 at 16q21 (MIM606151); BBS3 (ARL6) at 3p12 -q13 (MIM608845); BBS4 at 15q22.3 -q23 (MIM600374); BBS5 at 2q31 (MIM603650), MKKS BBS6 at 20p12 (MIM604896); BBS7 at 4q27 (MIM607590); BBS8 at 14q32.1 (MIM608132) and BBS9 (PTHB1) (MIM607968) at 7p14. 7 -20 However, mutations in BBS1-9 only accounted for only a small portion of BBS patients, indicating the existence of additional BBS genes. Although the identification of additional BBS genes in the presence of marked locus heterogeneity is challenging, genetic linkage studies in consanguineous families provide a powerful strategy for identifying novel recessive disease genes. In order to map novel BBS genes we undertook genetic linkage studies in a large Omani BBS kindred. We mapped a novel locus to chromosome 12q21.2 that overlapped the recently described BBS10 locus 21 and, furthermore, confirmed mutations in the BBS10 gene, FLJ23560. We also excluded linkage to the recently described BBS11 locus on chromosome 9q33. 
Patients and methods
Clinical ascertainment and phenotype A consanguineous Omani family (F1, see Figure 1 ) presented with characteristic features of BBS to the Paediatric Ophthalmology service at Sultan Qaboos University Hospital. The detailed clinical features of four affected family members are summarized in Table 1 . After institutional approval and informed consent from the patients, parents and unaffected relatives, blood was collected for DNA extraction from 14 family members (marked with a* in Figure 1 ) and, following DNA extraction, microsatellite and SNP-microarray genotyping studies were instigated. Mutation analysis of FLJ23560 was also undertaken in 11 additional BBS kindreds (F2 -12). This included seven Pakistani BBS kindreds (F2 -F8) and four consanguineous BBS families (two with two unaffected individuals and each with a single affected individual) in whom SNP-based microarray studies had demonstrated autozygous regions at (12q21.2). 20 
Molecular studies
Microsatellite genotyping studies DNA was extracted from all patient blood samples using the Puregene extraction kit from Gentra, and stored at À801C. Primers for microsatellite markers flanking BBS1-9 were synthesized and genotyping performed (details available on request).
SNP genotyping studies Three affected members of the Omani family were genotyped with the Affymetrix 10k 2.0 SNP microarray (as described previously for other families 23 ). SNP genotyping studies in the four small families with a BBS10 mutation have been reported previously. 20 Mutation analysis of CCT2, MDM2, RAB21, TBC1D15 and VMDL2L3 was performed by direct sequencing using the ABI Big Dye Reaction Mix and standard methodology (details of primer sequences and methods available on request). Mutation analysis of FLJ23560 (C12orf58) was performed as reported by Stoetzel et al.
21

Results
Genetic linkage studies
After excluding linkage to BBS1-9, (data not shown), we initiated a genome-wide linkage scan in three affected individuals. Analysis of the data from Affymetrix 10k SNP arrays 24 revealed a common 10.1 Mb region of autozygosity at 12q15 -q21.2 (between 67.2 and 77.3 Mb) shared by each of the four patients analysed (see Figure 2 ) and supplementary Table. Genotyping of microsatellite markers (D12S1294, D12S375, D12S1680, D12S1693, D12S1722, RH27150, SHGC-56430, D12S1052, D12S1660) confirmed linkage (peak lod score at D12S1722 of 8.3 y ¼ 0.0) and a target interval of 10.1 Mb.
Mutation analysis of candidate genes
Thirty-three known and 24 predicted genes were contained in the 10. Table 1 ). 21 we then analysed FLJ23560 (C12orf58) and detected a homozygous frameshift mutation, c.995_999delAAGA (p.Q242fs258X), in all four affected individuals tested ( Figure 3 ). All parents of affected individuals were heterozygous for the mutation and unaffected siblings were heterozygous or homozygous wild-type. Furthermore the, p.Q242fs258X mutation was not detected in 72 Arab control chromosomes. Mutation analysis of seven unrelated Pakistani BBS probands from consanguineous families (three of which were unlinked to 12q15 -q21.2 (data not shown) revealed normal wild-type sequence in six cases. In one family a single affected individual was homozygous for a missense substitution (p.Pro539Leu, 1880C4T) that had been reported as a polymorphic variant by Stoetzel et al. 21 In addition, protein structure predictions suggested that the substitution would not have a major effect on FLJ23560 protein structure (data not shown Affected individuals in two of the families were homozygous for the recently reported common BBS10 mutation, C91fsX95. The proband of one family was homozygous for the recently reported V707fsX708 mutation, whereas the proband of the remaining family was homozygous for a novel frameshift mutation, N364fsX368.
Discussion
We initially mapped a novel BBS locus to chromosome 12q21.2 and then detected inactivating mutations in FLJ23560 in five BBS kindreds. Thus, our study confirms that FLJ23560 is the BBS10 gene, as reported recently by Stoetzel et al. 21 The BBS genes identified to date represent a range of putative functions with some BBS gene products having been localized to basal bodies and centrosomes (BBS4, BBS5, BBS7 and BBS8. 16, 27, 28 Roles in ciliary function, intracellular and intraflagellar transport, and maintenance of planar cell polarity have been implicated as key pathways in the pathogenesis of BBS. 16,22,28 -33,34 However, FLJ23560 (C12orf58) differs from other BBS genes by encoding a group II chaperonin that is not conserved in invertebrates. 21 Although BBS6 (also known as MKKS) is also thought to encode a chaperonin, 27 BBS6 and BBS10 differ as BBS10 is restricted to vertebrates and contains a functional motif responsible for ATP hydrolysis that is found in all group II chaperonins, 35 but which is not present in BBS6. 21, 27 Hence, it appears that BBS10 may represent a novel chaperonin subfamily. At present the relationship between BBS10 and ciliary body/intraflagellar transport function is not known, but if the BBS10 protein does function as a chaperonin then it may regulate the folding or stability of other ciliary or basal body proteins. Three of the four BBS10 mutations characterized in our cases were also detected by Stoetzel et al. 21 The Q242fs258X homozygous truncating mutation identified in the large Omani family (F1) was also found in a homozygous state in a Lebanese and in the heterozygous state (a second mutation was not identified) in a Middle Eastern family. Previously most Middle Eastern BBS families did not have a mutation in BB1-9, but BBS10 mutations were detected in 6/26 families of Middle Eastern ancestry. 21 The clinical phenotype of BBS is extremely variable and genotype -phenotype correlations are hindered by marked locus heterogeneity, compound heterozygosity in nonconsanguineous cases and suggestions of digenic and oligigenic inheritance in some families. 25, 36, 37 The identification and detailed clinical phenotyping of cohorts of BBS patients homozygous for common founder or recurrent mutations will facilitate the identification of genotype -phenotype determinants.
The mapping of BBS10 to 12q15 -q21.2 in the large Omani BBS family illustrates the power of an autozygosity mapping strategy even in the presence of locus heterogeneity. The availability of SNP microarrays for genotyping In addition, among non-BBS9 linked families, four were homozygous at 12q21.1. Each of these families was found to harbour a FLJ23560/BBS10 mutation further demonstrating the potential for homozygosity mapping with SNP arrays for gene identification studies in small, consanguineous families. Recently, Woods et al 38 reported that the mean size of the homozygous segment associated with recessive disease in a consanguineous family was 26 cM (range 5 -70 cM). Although in many families the frequency of homozygous regions was higher than that predicted by simple models of consanguinity -which would be expected to impair autozygosity mapping studies, the longest homozygous segment was the disease-associated segment in 17% of individuals. In the large Omani family BBS10 was included in the largest autozygous region and analysis of the four small families used for autozygosity mapping in the current study revealed that the disease locus was the longest segment of autozygosity in two families and within the second longest region of autozygosity in the remaining two families. Thus, the ascertainment and sampling of both large and small consanguineous recessive disease families can have a critical role in the identification of human disease genes and the functional annotation of the human genome. Figure 3 Sequence traces from Omani family with a p.Q242fs258X mutation in BBS10.
